Wolverine Asset Management’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
Wolverine Asset Management's IBER.U Position: Q4 2022 in Review
Wolverine Asset Management sold out of Ibere Pharmaceuticals Units (IBER.U) in Q4 2022, closing a stake of 9,500 shares — an estimated $94K sold.
Wolverine Asset Management first reported a position in IBER.U in Q1 2021 and held it in 7 quarters. The position peaked at $154K in Q2 2022. 10 funds tracked by Wall St. Rank hold IBER.U as of Q4 2022.
- Wolverine Asset Management reported no remaining Ibere Pharmaceuticals Units position as of Q4 2022 after selling out during the quarter.
- Wolverine Asset Management sold 9,500 Ibere Pharmaceuticals Units shares in Q4 2022, an estimated $94K.
- Wolverine Asset Management first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 7 quarters.
- Wolverine Asset Management's Ibere Pharmaceuticals Units position peaked at $154K in Q2 2022.
- 10 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q4 2022.
Based on Wolverine Asset Management's 13F filing for Q4 2022, filed 1 Feb 2023.